|
Aug 7
|
Viatris to announce at least one divestiture in 3Q
|
|
Aug 7
|
Is Viatris Inc. (VTRS) Modestly Overvalued?
|
|
Aug 7
|
Viatris (VTRS) Q2 Earnings Beat, Generics Business Grows
|
|
Aug 7
|
Viatris (VTRS) Q2 Earnings and Revenues Beat Estimates
|
|
Aug 7
|
Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]
|
|
Aug 7
|
Viatris and Mapi Pharma Announce FDA Acceptance of New Drug Application Filing for GA Depot for the Treatment of Relapsing Forms of Multiple Sclerosis
|
|
May 1
|
Viatris (VTRS) Gains As Market Dips: What You Should Know
|
|
Apr 30
|
27 Largest Biotech Companies in the US
|
|
Apr 27
|
Want to Collect $1,100 in Dividends? Invest $20,000 in These 2 Stocks
|